AUD 0.03
(3.7%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 | 21.31 Million AUD | 40.13% |
2023 | 15.2 Million AUD | -34.74% |
2022 | 23.3 Million AUD | 26.81% |
2021 | 18.37 Million AUD | 53.97% |
2020 | 11.93 Million AUD | -26.42% |
2019 | 16.22 Million AUD | -10.01% |
2018 | 18.02 Million AUD | 76.55% |
2017 | 10.21 Million AUD | -21.16% |
2016 | 12.94 Million AUD | -16.88% |
2015 | 15.57 Million AUD | 1134.74% |
2014 | 1.26 Million AUD | 357.7% |
2013 | 275.67 Thousand AUD | -40.82% |
2012 | 465.79 Thousand AUD | -59.17% |
2011 | 1.14 Million AUD | -14.98% |
2010 | 1.34 Million AUD | -33.16% |
2009 | 2 Million AUD | -31.75% |
2008 | 2.94 Million AUD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q2 | 14.16 Million AUD | 0.0% |
2024 Q4 | 21.31 Million AUD | 0.0% |
2024 FY | 21.31 Million AUD | 40.13% |
2023 Q4 | 15.2 Million AUD | 0.0% |
2023 FY | 15.2 Million AUD | -34.74% |
2023 Q2 | 17.81 Million AUD | 0.0% |
2022 Q2 | 25.65 Million AUD | 0.0% |
2022 FY | 23.3 Million AUD | 26.81% |
2022 Q4 | 23.3 Million AUD | 0.0% |
2021 Q2 | 16.56 Million AUD | 0.0% |
2021 FY | 18.37 Million AUD | 53.97% |
2021 Q4 | 18.37 Million AUD | 0.0% |
2020 Q2 | 13.21 Million AUD | 0.0% |
2020 FY | 11.93 Million AUD | -26.42% |
2020 Q4 | 11.93 Million AUD | 0.0% |
2019 FY | 16.22 Million AUD | -10.01% |
2019 Q2 | 20.21 Million AUD | 0.0% |
2019 Q4 | 16.22 Million AUD | 0.0% |
2018 Q4 | 18.02 Million AUD | 0.0% |
2018 FY | 18.02 Million AUD | 76.55% |
2018 Q2 | 10.38 Million AUD | 0.0% |
2017 Q2 | 10.88 Million AUD | 0.0% |
2017 Q4 | 10.21 Million AUD | 0.0% |
2017 FY | 10.21 Million AUD | -21.16% |
2016 FY | 12.94 Million AUD | -16.88% |
2016 Q4 | 12.94 Million AUD | 0.0% |
2016 Q2 | 14.63 Million AUD | 0.0% |
2015 Q4 | 15.57 Million AUD | 0.0% |
2015 Q2 | 8.43 Million AUD | 0.0% |
2015 FY | 15.57 Million AUD | 1134.74% |
2014 Q2 | 1.51 Million AUD | 0.0% |
2014 Q4 | 1.26 Million AUD | 0.0% |
2014 FY | 1.26 Million AUD | 357.7% |
2013 Q4 | 275.67 Thousand AUD | 0.0% |
2013 Q2 | 460.52 Thousand AUD | 0.0% |
2013 Q1 | 460.52 Thousand AUD | -1.13% |
2013 FY | 275.67 Thousand AUD | -40.82% |
2013 Q3 | 275.67 Thousand AUD | -40.14% |
2012 FY | 465.79 Thousand AUD | -59.17% |
2012 Q4 | 465.79 Thousand AUD | 0.0% |
2011 FY | 1.14 Million AUD | -14.98% |
2011 Q4 | 1.14 Million AUD | 0.0% |
2010 Q4 | 1.34 Million AUD | 0.0% |
2010 FY | 1.34 Million AUD | -33.16% |
2009 FY | 2 Million AUD | -31.75% |
2009 Q4 | 2 Million AUD | 0.0% |
2008 Q4 | 2.94 Million AUD | 0.0% |
2008 FY | 2.94 Million AUD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
AdAlta Limited | 5.57 Million AUD | -282.413% |
Acrux Limited | 8.96 Million AUD | -137.776% |
AnteoTech Limited | 9.38 Million AUD | -127.177% |
Argenica Therapeutics Limited | 16.37 Million AUD | -30.129% |
Arovella Therapeutics Limited | 13.28 Million AUD | -60.424% |
Anatara Lifesciences Ltd | 1.67 Million AUD | -1175.074% |
Alterity Therapeutics Limited | 19.22 Million AUD | -10.862% |
Amplia Therapeutics Limited | 14.84 Million AUD | -43.562% |
Avecho Biotechnology Limited | 7.31 Million AUD | -191.173% |
Bio-Gene Technology Limited | 3.15 Million AUD | -574.514% |
Biome Australia Limited | 8.27 Million AUD | -157.49% |
Biotron Limited | 493.47 Thousand AUD | -4218.724% |
Botanix Pharmaceuticals Limited | 112.46 Million AUD | 81.05% |
BTC Health Limited | 5.14 Million AUD | -313.919% |
Chimeric Therapeutics Limited | 15.27 Million AUD | -39.538% |
CSL Limited | 56.93 Billion AUD | 99.963% |
Clarity Pharmaceuticals Ltd | 154.62 Million AUD | 86.217% |
Clinuvel Pharmaceuticals Limited | 231.12 Million AUD | 90.779% |
Cynata Therapeutics Limited | 8.38 Million AUD | -154.067% |
Dimerix Limited | 32.07 Million AUD | 33.563% |
EZZ Life Science Holdings Limited | 25.55 Million AUD | 16.594% |
Hexima Limited | 2.26 Million AUD | -839.261% |
Island Pharmaceuticals Limited | 2.56 Million AUD | -731.043% |
Immuron Limited | 15.54 Million AUD | -37.054% |
Immutep Limited | 147.44 Million AUD | 85.546% |
Imugene Limited | 151.39 Million AUD | 85.923% |
Invex Therapeutics Ltd | 6.12 Million AUD | -248.23% |
Memphasys Limited | 12.43 Million AUD | -71.453% |
Nanollose Limited | 241.95 Thousand AUD | -8708.34% |
Neuren Pharmaceuticals Limited | 247.97 Million AUD | 91.405% |
Noxopharm Limited | 6.78 Million AUD | -214.16% |
NeuroScientific Biopharmaceuticals Limited | 5.43 Million AUD | -292.06% |
Nyrada Inc. | 5.9 Million AUD | -260.774% |
Orthocell Limited | 26.61 Million AUD | 19.926% |
PharmAust Limited | 11.12 Million AUD | -91.57% |
Patrys Limited | 4.16 Million AUD | -412.11% |
Paradigm Biopharmaceuticals Limited | 27.39 Million AUD | 22.192% |
Proteomics International Laboratories Limited | 10.87 Million AUD | -95.969% |
Prescient Therapeutics Limited | 20.39 Million AUD | -4.507% |
PYC Therapeutics Limited | 91.23 Million AUD | 76.642% |
Race Oncology Limited | 20.22 Million AUD | -5.355% |
Radiopharm Theranostics Limited | 72.03 Million AUD | 70.415% |
Recce Pharmaceuticals Ltd | 6.36 Million AUD | -234.586% |
Starpharma Holdings Limited | 36.81 Million AUD | 42.109% |
Telix Pharmaceuticals Limited | 398.3 Million AUD | 94.649% |
Tissue Repair Ltd | 19.38 Million AUD | -9.914% |
Zelira Therapeutics Limited | 5.18 Million AUD | -311.155% |